AI assistant
PCAS — Interim / Quarterly Report 2011
Oct 7, 2011
1590_iss_2011-10-07_20519093-b662-4a6f-95b2-f422c72df826.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
P r o d u i t s C h i m i q u e s A u x i l i a i r e s e t d e S y n t h è s e
Registered office: 23 rue Bossuet – Z.I. de la Vigne aux Loups – 91160 LONGJUMEAU French limited company (SA) ) with capital of €13,705,865 EVRY trade and company register 622 019 503
Q u a r t e r l y f i n a n c i a l r e p o r t i n g A s o f 3 0 S e p t e m b e r 2 0 1 1
Business update
| (in thousands of euros) | 2011 | 2010 | % change |
|---|---|---|---|
| First Quarter | 44,053 | 41,434 | 6,3% |
| including Pharmaceutical Synthesis | 27,147 | 26,603 | 2,0% |
| including Specialty Chemicals | 16,906 | 14,831 | 14,0% |
| Second Quarter | 41,789 | 42,698 | -2,1% |
| including Pharmaceutical Synthesis | 26,457 | 28,100 | -5,8% |
| including Specialty Chemicals | 15,332 | 14,598 | 5,0% |
| Third Quarter | 33,481 | 33,658 | -0,5% |
| including Pharmaceutical Synthesis | 19,530 | 18,394 | 6,2% |
| including Specialty Chemicals | 13,951 | 15,264 | -8,6% |
| Total as of 30 September | 119,323 | 117,790 | 1,3% |
| including Pharmaceutical Synthesis | 73,134 | 73,097 | 0,1% |
| including Specialty Chemicals | 46,189 | 44,693 | 3,3% |
The PCAS Group's consolidated revenues at 30 September 2011came in 1.3% higher than the same period the previous year.
Pharmaceutical Synthesis
Over the first five months of the year, business was affected by the planned reduction in the contribution by the new contract between PCAS and Sanofi, effective since 31 May 2010. Excluding this contract, the Exclusive and Non-Exclusive Pharma business is up 10.5% at 30 September 2011.
Fine Specialty Chemicals
With growth of 3.3% at 30 September 2011, the Fine Specialty Chemicals business contracted by 8.6% during the third quarter of 2011 in relation to 2010, reflecting the economic slowdown seen since the summer.
Key operations and events for the quarter
No important events likely to have a significant impact on the company's business or situation occurred during the third quarter of 2011.
Outlook for the current year
The high level of sales expected for the fourth quarter should lead to earnings growth in 2011.
Next date : 2011 earnings, February 22nd, 2012
About PCAS
PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.
Longjumeau, October 7th, 2011